Skip to main content

Home/ Health Secrets/ Group items tagged chronic

Rss Feed Group items tagged

drreads

Chronic inflammation: symptoms, causes, treatment - Dr Reads - 0 views

  •  
    chronic inflammation
Alex Parker

Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views

  •  
    PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).
1 - 2 of 2
Showing 20 items per page